C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2011
12/29/2011	CA2803391A1 Colon and pancreas cancer specific antigens and antibodies
12/29/2011	CA2803058A1 Homodimeric protein constructs
12/29/2011	CA2802756A1 Compositions and methods for stabilizing protein-containing formulations
12/28/2011	EP2400029A2 Methods for cyclic nucleotide determination
12/28/2011	EP2400021A2 ErbB3 based methods and compositions for treating neoplasms
12/28/2011	EP2400019A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400018A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400017A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400016A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400015A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400014A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400013A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400012A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400011A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400010A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400009A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400008A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400007A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400006A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400005A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400004A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400003A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400002A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400001A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400000A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399999A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399998A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399997A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399996A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399995A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399993A1 Hypo-immunogenic streptavidin and use thereof
12/28/2011	EP2399991A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
12/28/2011	EP2399937A1 Anti-human alpha9 integrin antibody and use thereof
12/28/2011	EP2399936A2 Anti-CD154 antibodies
12/28/2011	EP2399935A2 An anti-CD137 antibody as an agent in the treatment of cancer and glycosylation variants thereof
12/28/2011	EP2399934A1 Novel monoclonal antibody, and use thereof
12/28/2011	EP2399933A1 Binding partner of the placental growth factor, in particular antibodies opposed to the placental growth factor, production and use of same
12/28/2011	EP2399932A1 Compositions and methods for modulating immune responses
12/28/2011	EP2399613A1 Fractionation of plasma using caprylic acid
12/28/2011	EP2399605A1 Extending time to disease progression or survival in cancer patients
12/28/2011	EP2399604A1 Novel antibody formulation
12/28/2011	EP2399135A2 Method for inhibiting neurodegeneration
12/28/2011	EP2398913A1 Method for obtaining immunoglobulin encoding nucleic acid
12/28/2011	EP2398902A1 Methods and compositions for diagnosis and treatment of cancer
12/28/2011	EP2398829A2 Humanized antibodies that bind to cd19 and their uses
12/28/2011	EP2398828A2 Specific binding proteins and uses thereof
12/28/2011	EP2398827A2 Improved anti-tnfr1 polypeptides, antibody variable domains&antagonists
12/28/2011	EP2398826A2 Improved anti-serum albumin binding variants
12/28/2011	EP2398825A2 Improved anti-serum albumin binding variants
12/28/2011	EP2398824A1 Means and methods for manufacturing highly pure neurotoxin
12/28/2011	EP2398823A1 Monoclonal antibodies against vaginolysin
12/28/2011	EP2398818A1 Means for purifying a protein of blood plasma and methods for implementing same
12/28/2011	EP2398498A2 Antibody molecules having specificity for human ox40
12/28/2011	EP2398494A2 Proproteins and methods of use thereof
12/28/2011	EP2398491A1 Sphingosine 1-phosphate antagonism
12/28/2011	EP2386577A9 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof
12/28/2011	EP2385071A9 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/28/2011	EP1667716B1 Cytotoxicity mediation of cells evidencing surface expression of cd44
12/28/2011	EP1308730B1 Method of detecting or assaying hbv
12/28/2011	CN102300879A 双重可变结构域免疫球蛋白及其用途 Dual variable domain immunoglobulins and their use
12/28/2011	CN102300878A 与溶基质蛋白酶1特异地发生反应的单克隆抗体 Occurrence and stromelysin-1 monoclonal antibody that reacts specifically
12/28/2011	CN102300877A 与糖尿病肾病相关的尿及血清的生物标记 And diabetic nephropathy urine and serum biomarkers
12/28/2011	CN102300876A 针对组织因子途径抑制剂(tfpi)的抗体 For tissue factor pathway inhibitor (tfpi) antibody
12/28/2011	CN102300875A 肾病相关的生物标记 Nephropathy biomarkers
12/28/2011	CN102300874A Tmem154多肽和多核苷酸及其作为产生药物和生物制品的药物靶标的用途 Tmem154 polypeptides and polynucleotides and produce drugs and biological products as potential targets for drug use
12/28/2011	CN102300873A 针对n-钙黏着蛋白的完全人抗体 For n- cadherins fully human antibodies
12/28/2011	CN102300586A 稳定的药物组合物，其含有至少一种单克隆抗体和至少一种包含疏水性取代基的两亲性多糖 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one substituent comprising a hydrophobic amphipathic polysaccharide
12/28/2011	CN102297969A 一种鉴别诊断传统美洲型和变异型猪繁殖与呼吸综合征的免疫荧光试剂的制备方法 A differential diagnosis method for preparing traditional American type and variant of porcine reproductive and respiratory syndrome immunofluorescence reagent
12/28/2011	CN102297968A 辅助诊断结核病的试剂盒 TB diagnosis kit
12/28/2011	CN102297967A 一种pvy/cmv表面等离子体共振检测方法 Resonance detection method pvy / cmv surface plasmon
12/28/2011	CN102297798A 朊病毒蛋白配基和使用方法 Prion protein ligands and methods of use
12/28/2011	CN102296052A 一种针对ppGalNAc-T13多克隆抗体的特异性抗原肽及其制备与应用 One for ppGalNAc-T13 polyclonal antibody specific antigen peptide and its preparation and application
12/28/2011	CN102296050A 抗人IL-1α单克隆抗体及其应用 Anti-human IL-1α monoclonal antibody and uses thereof
12/28/2011	CN102296049A 快速检测膝沟藻毒素gtx2/3的酶联免疫试剂盒及其制法 Rapid detection gonyautoxins ELISA gtx2 / 3 kit Jiqizhifa
12/28/2011	CN102295703A 鉴定对用抗ErbB2抗体处理响应的肿瘤的方法 Identification of treatment with anti-ErbB2 antibody response to tumor method
12/28/2011	CN102295702A 一种针对t细胞受体可变区特异性单抗的制备方法 A method of preparing t-cell receptor variable region-specific monoclonal antibody against
12/28/2011	CN102295701A 抗胸腺素α原多克隆抗体及其制备方法与应用 Former anti-thymosin α polyclonal antibody preparation method and application
12/28/2011	CN102295698A 环孢霉素a免疫原、特异性抗体、检测试剂及检测试剂盒 Cyclosporine a immunogen-specific antibodies, detection reagents and test kits
12/28/2011	CN102295681A Eb病毒潜伏膜蛋白2b细胞表位及应用 Eb virus latent membrane protein 2b cell epitopes and Applications
12/28/2011	CN101696242B 人源抗狂犬病毒中和抗体Fab及其制备方法和应用 Human anti-rabies virus neutralizing antibody Fab and its preparation method and application
12/28/2011	CN101684156B 人TNFα单克隆抗体、其PEG化纳米颗粒及其应用 Human TNFα monoclonal antibody PEG nanoparticles and its application
12/28/2011	CN101671394B 抗hAPE1蛋白的抗体及其制备方法与应用该抗体的试剂盒 HAPE1 anti-protein antibodies and methods of application of this antibody kit
12/28/2011	CN101607994B 一种鸭病毒性肝炎精制蛋黄抗体的制备方法 A method of preparing duck egg yolk antibodies purified viral
12/28/2011	CN101597596B 抗岩沙海葵毒素单克隆抗体及其试剂盒、产生该单克隆抗体的杂交瘤细胞系以及它们的用途 Anti Palytoxin monoclonal antibodies and kits, hybridoma cell lines producing the monoclonal antibodies and their use
12/28/2011	CN101463083B 与A-beta寡聚体特异性结合的基因工程单克隆抗体 And A-beta oligomer-specific binding of monoclonal antibodies genetically engineered
12/28/2011	CN101463082B 与A-beta寡聚体特异性结合的基因工程单克隆抗体 And A-beta oligomer-specific binding of monoclonal antibodies genetically engineered
12/28/2011	CN101368173B 抗人cd44的工程抗体、载体、试剂盒及其用途 Anti-human cd44 engineered antibody, vectors, kits and uses thereof
12/28/2011	CN101014622B 用于检测分枝杆菌感染的富集抗体，应用方法和应用其的诊断检测 Enrichment antibodies for the detection of mycobacterial infection, the application of methods and applications of its diagnostic tests
12/27/2011	US8084595 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
12/27/2011	US8084586 Doxorubicin immunoassay
12/27/2011	US8084585 Anti-ILT7 antibody
12/27/2011	US8084584 Methods for stabilizing proteins
12/27/2011	US8084583 RS7 antibodies
12/27/2011	US8084582 Enhancing macrophage activation via co-administering CD20 specific and Fc gamma RIIIa immunoglobulins; targeted treatment of cell proliferative disorders
12/27/2011	US8084580 Therapeutic human albumin solutions with low prekallikrein activator (PKA) activity and process for obtaining them
12/27/2011	US8084434 Using modulators which alter protein DNA binding as tool in prevention and treatment of cell proliferative disorders
12/27/2011	US8084415 Uteroglobin in the treatment of IGA mediated nephropathy
12/27/2011	US8084413 Urocortin-III and uses thereof
12/27/2011	US8084249 Vector
12/27/2011	US8084233 Nucleic acids encoding anti-IL-12 antibody

1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 1494